Prix De L'Action
46.04
Variation Quotidienne
0.08 0.17%
Mensuellement
-1.56%
Annuel
-16.22%
Q2 Prévisions
45.74




Ebitda Changement Date
AbbVie USD 5.37B 1.85B 2025-12
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 4.38B 846M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Canopy Growth CAD -2.87M 19.49M 2025-12
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Drreddys Laboratories INR 21.59B 1.49B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Galapagos EUR 2.42M 161.13M 2025-09
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 1.12B 2.24B 2025-12
Glaxosmithkline GBP 4.75B 1.52B 2025-09
J&J USD 7.19B 2.32B 2025-12
Merck USD 8.39B 1.97B 2025-09
Novartis USD 5.3B 530M 2026-03
Novartis USD 5.84B 235M 2025-09
Pacira USD 38.71M 10.65M 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 90.82M 3.99M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Sanofi EUR 5.66B 3.77B 2025-09
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
UCB EUR 1.6B 570M 2025-12
Zoetis USD 1.04B 87M 2025-09